{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:40:17Z","timestamp":1777473617744,"version":"3.51.4"},"reference-count":41,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Patients with relapsed\/refractory T-cell acute lymphoblastic leukemia (T-ALL) have a dismal prognosis largely mediated by nonsustained responses to chemotherapy and few targeted therapy options. Surface antigen targets in T-ALL include CD2, CD5, CD7, and CD38; however, ongoing clinical development of these targets is challenged by (1) T-cell fratricide during manufacturing, (2) T-cell depletion during treatment, and (3) high frequency of target-negative relapse. Here, we use a combination of flow cytometry, single-cell genomics, and bulk RNA sequencing to identify CC chemokine receptor type 4 (CCR4) as a novel surface target in T-ALL. We analyzed the T-ALL microenvironment from 40 patients treated on the AALL0434 clinical trial and identified a subpopulation of bone marrow\u2013enriched CCR4+ FOXP3+ T-regulatory cells that express immune checkpoints (PD-1 and TIGIT) and could be targeted with anti-CCR4 therapy. Finally, we describe the preclinical efficacy of an anti-CCR4 chimeric antigen receptor T-cell therapy in in vitro and in vivo models, paving the way for future translational efforts in chemotherapy-refractory T-ALL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018600","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:00:03Z","timestamp":1770840003000},"page":"2676-2686","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"10","author":[{"given":"Jason","family":"Xu","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"2Department of Internal Medicine, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"McCoy","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Martinez","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3057-3550","authenticated-orcid":false,"given":"Jonathan H.","family":"Sussman","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gao","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffaney","family":"Vincent","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5616-3330","authenticated-orcid":false,"given":"Hunter","family":"Wang","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8300-8503","authenticated-orcid":false,"given":"Connie","family":"Ma","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0786-8035","authenticated-orcid":false,"given":"Omar","family":"Elghawy","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4083-5083","authenticated-orcid":false,"given":"Gregory M.","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1620-3493","authenticated-orcid":false,"given":"Austin G.","family":"Yang","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6128-9985","authenticated-orcid":false,"given":"Petri","family":"P\u00f6l\u00f6nen","sequence":"additional","affiliation":[{"name":"4Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keanu","family":"Natan","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5350-3386","authenticated-orcid":false,"given":"Rawan","family":"Shraim","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3022-8052","authenticated-orcid":false,"given":"Haley","family":"Newman","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-0618","authenticated-orcid":false,"given":"Ted J.","family":"Hofmann","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Scoma","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"DiNofia","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-3957","authenticated-orcid":false,"given":"Stephen P.","family":"Hunger","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun J.","family":"Yang","sequence":"additional","affiliation":[{"name":"5Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"name":"4Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0691-356X","authenticated-orcid":false,"given":"Kathrin M.","family":"Bernt","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-4060","authenticated-orcid":false,"given":"Elizabeth O.","family":"Hexner","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan A.","family":"Grupp","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0241-3557","authenticated-orcid":false,"given":"Carl H.","family":"June","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"6Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-5567","authenticated-orcid":false,"given":"Kai","family":"Tan","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"7Center for Single Cell Biology, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7373-8987","authenticated-orcid":false,"given":"David T.","family":"Teachey","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8005-3836","authenticated-orcid":false,"given":"Caroline","family":"Diorio","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"3","key":"2026042809470437800_bib1","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","article-title":"Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia","volume":"20","author":"Teachey","year":"2019","journal-title":"Lancet Oncol"},{"issue":"9","key":"2026042809470437800_bib2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2411680","article-title":"Blinatumomab in standard-risk B-cell acute lymphoblastic leukemia in children","volume":"392","author":"Gupta","year":"2025","journal-title":"N Engl J Med"},{"issue":"9","key":"2026042809470437800_bib3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia","volume":"376","author":"Kantarjian","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"2026042809470437800_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2312948","article-title":"Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults","volume":"391","author":"Litzow","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"2026042809470437800_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"2026042809470437800_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood-2023-181282","article-title":"Fratricide-resistant anti-CD2 chimeric antigen receptor T-cells with endogenous CD2 knockout are highly effective against T-cell neoplasms","volume":"142","author":"Angelos","year":"2023","journal-title":"Blood"},{"issue":"12","key":"2026042809470437800_bib7","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/s41375-023-02039-z","article-title":"An \u201coff-the-shelf\u201d CD2 universal CAR-T therapy for T-cell malignancies","volume":"37","author":"Xiang","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"2026042809470437800_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41591-024-03282-2","article-title":"Allogeneic CD5-specific CAR-T therapy for relapsed\/refractory T-ALL: a phase 1 trial","volume":"31","author":"Pan","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"2026042809470437800_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood-2019-129559","article-title":"Safety and anti-tumor activity of CD5 CAR T-cells in patients with relapsed\/refractory T-cell malignancies","volume":"134","author":"Hill","year":"2019","journal-title":"Blood"},{"issue":"16","key":"2026042809470437800_bib10","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1200\/JCO.2023.41.16_suppl.7002","article-title":"Enhanced anti-tumor activity of CD5 CAR T cells manufactured with tyrosine kinase inhibitors in patients with relapsed\/refractory T-ALL","volume":"41","author":"Hill","year":"2023","journal-title":"J Clin Oncol"},{"issue":"97","key":"2026042809470437800_bib11","doi-asserted-by":"crossref","first-page":"eadn6509","DOI":"10.1126\/sciimmunol.adn6509","article-title":"CD5 deletion enhances the antitumor activity of adoptive T cell therapies","volume":"9","author":"Patel","year":"2024","journal-title":"Sci Immunol"},{"issue":"30","key":"2026042809470437800_bib12","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1200\/JCO.21.00389","article-title":"Donor-derived CD7 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia: first-in-human, phase I trial","volume":"39","author":"Pan","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"2026042809470437800_bib13","first-page":"321","article-title":"Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL\/LBL: first-in-human phase 1 clinical trial","volume":"140","author":"Lu","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2026042809470437800_bib14","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood-2021-147632","article-title":"The impact of the immunophenotyping characteristics of patients\u2019 peripheral blood on the manufacturing and clinical outcome of CD7-targeted chimeric antigen receptor T cells","volume":"138","author":"Zhang","year":"2021","journal-title":"Blood"},{"issue":"5","key":"2026042809470437800_bib15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1158\/1078-0432.CCR-20-1271","article-title":"Eradication of T-ALL cells by CD7-targeted universal CAR-T cells and initial test of ruxolitinib-based CRS management","volume":"27","author":"Li","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"21","key":"2026042809470437800_bib16","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.2024024493","article-title":"Daratumumab in pediatric relapsed\/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study","volume":"144","author":"Bhatla","year":"2024","journal-title":"Blood"},{"issue":"14","key":"2026042809470437800_bib17","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1182\/bloodadvances.2022008327","article-title":"Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma","volume":"7","author":"Watanabe","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"2026042809470437800_bib18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"2026042809470437800_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s43018-024-00863-5","article-title":"A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia","volume":"6","author":"Xu","year":"2025","journal-title":"Nat Cancer"},{"issue":"2","key":"2026042809470437800_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2024.01.006","article-title":"An atlas of cells in the human tonsil","volume":"57","author":"Massoni-Badosa","year":"2024","journal-title":"Immunity"},{"issue":"16","key":"2026042809470437800_bib21","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1182\/bloodadvances.2022007059","article-title":"CD38 as a pan-hematologic target for chimeric antigen receptor T cells","volume":"7","author":"Glisovic-Aplenc","year":"2023","journal-title":"Blood Adv"},{"issue":"8039","key":"2026042809470437800_bib22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41586-024-07944-6","article-title":"A spatial human thymus cell atlas mapped to a continuous tissue axis","volume":"635","author":"Yayon","year":"2024","journal-title":"Nature"},{"issue":"1","key":"2026042809470437800_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41556-022-01050-3","article-title":"PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia","volume":"25","author":"Xu","year":"2023","journal-title":"Nat Cell Biol"},{"issue":"2","key":"2026042809470437800_bib24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI130189","article-title":"Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes","volume":"130","author":"Meyer","year":"2020","journal-title":"J Clin Invest"},{"issue":"8027","key":"2026042809470437800_bib26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","article-title":"The genomic basis of childhood T-lineage acute lymphoblastic leukaemia","volume":"632","author":"P\u00f6l\u00f6nen","year":"2024","journal-title":"Nature"},{"issue":"12","key":"2026042809470437800_bib25","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1089\/hum.2011.070","article-title":"Treatment of advanced leukemia in mice with mRNA engineered T cells","volume":"22","author":"Barrett","year":"2011","journal-title":"Hum Gene Ther"},{"issue":"9","key":"2026042809470437800_bib27","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"2026042809470437800_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"2026042809470437800_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s43018-024-00863-5","article-title":"A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia","volume":"6","author":"Xu","year":"2025","journal-title":"Nat Cancer"},{"issue":"13","key":"2026042809470437800_bib30","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"2026042809470437800_bib31","doi-asserted-by":"crossref","first-page":"110396","DOI":"10.1016\/j.intimp.2023.110396","article-title":"Role of chemokines in T-cell acute lymphoblastic leukemia: from pathogenesis to therapeutic options","volume":"121","author":"Zhao","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2026042809470437800_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5858\/arpa.2022-0482-OA","article-title":"Evaluation of novel targets, including CC-chemokine receptor 4, in adult T-cell acute lymphoblastic leukemia\/lymphoma: a Mayo clinic clinical and pathologic study","volume":"148","author":"Khurana","year":"2024","journal-title":"Arch Pathol Lab Med"},{"issue":"21","key":"2026042809470437800_bib33","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.3390\/cancers13215542","article-title":"CCR4 as a therapeutic target for cancer immunotherapy","volume":"13","author":"Yoshie","year":"2021","journal-title":"Cancers"},{"key":"2026042809470437800_bib34","doi-asserted-by":"crossref","first-page":"1170968","DOI":"10.3389\/fimmu.2023.1170968","article-title":"Targeted CD7 CAR T-cells for treatment of T-lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"2026042809470437800_bib35","doi-asserted-by":"crossref","first-page":"e000630","DOI":"10.1136\/jitc-2020-000630","article-title":"Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy","volume":"8","author":"Tembhare","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"10","key":"2026042809470437800_bib36","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/1535-7163.MCT-21-0058","article-title":"Evaluation of preclinical activity of isatuximab in patients with acute lymphoblastic leukemia","volume":"20","author":"Wang","year":"2021","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"2026042809470437800_bib37","doi-asserted-by":"crossref","first-page":"e823","DOI":"10.1016\/S2352-3026(25)00228-5","article-title":"Emerging therapeutic strategies for mature T-cell and natural killer-cell lymphomas","volume":"12","author":"Tse","year":"2025","journal-title":"Lancet Haematol"},{"issue":"23","key":"2026042809470437800_bib38","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1182\/blood.2024028194","article-title":"Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cells","volume":"146","author":"Venkatesh","year":"2025","journal-title":"Blood"},{"issue":"7","key":"2026042809470437800_bib39","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/eji.202049043","article-title":"CCR4 in cutaneous T-cell lymphoma: Therapeutic targeting of a pathogenic driver","volume":"51","author":"Nicolay","year":"2021","journal-title":"Eur J Immunol"},{"issue":"9","key":"2026042809470437800_bib40","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/leu.2014.108","article-title":"The targeting of immunosuppressive mechanisms in hematological malignancies","volume":"28","author":"Andersen","year":"2014","journal-title":"Leukemia"},{"key":"2026042809470437800_bib41","doi-asserted-by":"crossref","first-page":"216726","DOI":"10.1016\/j.canlet.2024.216726","article-title":"PD-1 regulation in immune homeostasis and immunotherapy","volume":"588","author":"Gao","year":"2024","journal-title":"Cancer Lett"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2676\/2514246\/blooda_adv-2025-018600-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2676\/2514246\/blooda_adv-2025-018600-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:47:17Z","timestamp":1777384037000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/8\/2676\/566566\/CCR4-expression-defines-a-targetable-subset-of-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018600","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,28]]},"published":{"date-parts":[[2026,4,17]]}}}